Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 7, 2003, Pages 647-651

  Sánchez Luceros, Analía ^a,b   Meschengieser, Susana S ^b   Marchese, Carlos ^c   Votta, Roberto ^c   Casais, Patricia ^d   Woods, Adriana I ^a   Nadal, Maria V ^b   Salviú, María J ^b   Lazzari, Maria A ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d Rene Baron Foundation   (Argentina)

Author keywords

Factor VIII; Normal pregnancy; Normal puerperium; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; RISTOCETIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP; BLOOD GROUP O; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; PARITY; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; PUERPERIUM; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; CROSS-SECTIONAL STUDIES; FACTOR VIII; FEMALE; GESTATIONAL AGE; HUMANS; PARITY; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; VON WILLEBRAND FACTOR;

EID: 18244421527     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200310000-00005     Document Type: Article

References (23)

1. Kasper CK, Hoag MS, Aggeler PM, Stone S. Blood clotting factors in pregnancy: factor VIII concentrations in normal and AHF-deficient women. Obstet Gynecol 1964; 24:242-247.
2. Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52:176-182.
3. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79:1166-1170.
4. Bergmann F, Rotmensch S, Rosenzmweig B, How H, Chediak J. The role of von Willebrand factor in pre-eclampsia. Thromb Haemost 1991; 66:525-528.
5. Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A, Boneu B. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100:416-420.
6. He S, Silveira A, Hamsten A, Blombäck M, Bremme K. Haemostatic, endothelial, and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost 1999; 81: 538-542.
7. Fondevila CG, Meschengieser SS, Bermejo E, Lazzari MA. Persistence of low platelet adhesiveness in von Willebrand disease during pregnancy. Platelets 1997; 8:155-157.
8. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1:140-144.
9. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105:314-321.
10. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98:909-918.
11. Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68:282-285.
12. Foster PA, on behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. Thromb Haemost 1995; 74:784-790.
13. Martinez-Canaveri AA. Assay of factor VIII: one and two stage methods. Thromb Diath Haemorrh 1969; 35:263-266.
14. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15:45-52.
15. Kempfer AC, Silaf MR, Farias CE, Carballo GA, Woods AI, Lazzari MA. Binding of von Willebrand factor to collagen by flow cytometry. Am J Clin Pathol 1999; 111:418-423.
16. MacFarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, MacPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34:306-308.
17. Carreras Vescio LA, Rey JA, Marietta J. Estadistica sobre 47345 determinaciones de grupo sanguineo ABO y factor RHO. Rev Argent Transfus 1982; 2:45-67.
18. Noller KL, Bowie EJ, Kempers RD, Owen CA, Jr. Von Willebrand's disease in pregnancy. Obstet Gynecol 1973; 41:865-872.
19. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69:1691-1695.
20. Nitu-Whalley IC, Lee CA, Griffioen A, Jenkins PV, Pasi KJ. Type 1 von Willebrand disease: a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haematol 2000; 108:259-264.
21. Woods AI, Meschengieser SS, Blanco AN, Salviu0 MJ, Farias CE, Kempfer AC, Lazzari MA. Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease. Haematologica 2001; 86:420-427.
22. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985; 74:741-745.
23. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986; 76:1035-1039.